Ratings by Wedbush (Liana Moussatos)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/20/2023 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 9/6/2023 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 6/2/2023 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 3/6/2023 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 1/9/2023 | Albireo Pharma | ALBO | Downgrade | Neutral (Outperform) |
22.82 (44.15) |
93.47% | Details | |
| 11/3/2022 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 9/1/2022 | Liquidia Technologies | LQDA | Downgrade | Underperform (Neutral) |
5.77 (79.94) |
1285.44% | Details | |
| 8/17/2022 | Aerovate Therapeutics Inc | AVTE | Maintain | Outperform (N/A) |
|
Details | ||
| 8/16/2022 | Albireo Pharma | ALBO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2022 | Global Blood Therapeutics | GBT | Downgrade | Neutral (Outperform) |
63.84 (68.49) |
7.28% | Details | |
| 8/3/2022 | Axcella Health Inc. | AXLA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/13/2022 | Global Blood Therapeutics | GBT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/27/2022 | Axcella Health Inc. | AXLA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/31/2022 | Axcella Health Inc. | AXLA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/3/2022 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 1/21/2022 | Regulus Therapeutics | RGLS | Maintain | Neutral (N/A) |
|
Details | ||
| 1/13/2022 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 12/22/2021 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2021 | Liquidia Technologies | LQDA | Maintain | Neutral (N/A) |
|
Details | ||
| 10/25/2021 | Clearside Biomedical | CLSD | Maintain | Outperform (N/A) |
|
Details | ||
| 10/18/2021 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 10/1/2021 | Omeros Corp. | OMER | Downgrade | Underperform (Neutral) |
13.79 (9.69) |
-29.73% | Details | |
| 9/16/2021 | Albireo Pharma | ALBO | Maintain | Outperform (N/A) |
|
Details | ||
| 9/7/2021 | XOMA, Ltd. | XOMA | Downgrade | Neutral (Outperform) |
28.88 (40.17) |
39.09% | Details | |
| 8/2/2021 | Albireo Pharma | ALBO | Maintain | Outperform (N/A) |
|
Details | ||
| 7/26/2021 | Aerovate Therapeutics Inc | AVTE | New Coverage | Outperform (N/A) |
14.23 (2.68) |
-81.17% | Details | |
| 7/21/2021 | Albireo Pharma | ALBO | Maintain | Outperform (N/A) |
|
Details | ||
| 7/6/2021 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 6/17/2021 | Clearside Biomedical | CLSD | Maintain | Outperform (N/A) |
|
Details | ||
| 6/14/2021 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 5/14/2021 | Regulus Therapeutics | RGLS | Maintain | Neutral (N/A) |
|
Details | ||
| 5/13/2021 | Liquidia Technologies | LQDA | Maintain | Neutral (N/A) |
|
Details | ||
| 5/13/2021 | Graybug Vision | GRAY | Maintain | Neutral (N/A) |
|
Details | ||
| 4/5/2021 | United Therapeutics Corp. | UTHR | Maintain | Outperform (N/A) |
|
Details | ||
| 3/25/2021 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/10/2021 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 1/29/2021 | Lexicon Pharmaceuticals | LXRX | Downgrade | Neutral (Outperform) |
8.06 (2.39) |
-70.35% | Details | |
| 12/17/2020 | Albireo Pharma | ALBO | Maintain | Outperform (N/A) |
|
Details | ||
| 11/25/2020 | Eiger BioPharma | EIGR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/20/2020 | Liquidia Technologies | LQDA | Downgrade | Neutral (Outperform) |
3.40 (79.94) |
2251.18% | Details | |
| 11/16/2020 | Omeros Corp. | OMER | Maintain | Neutral (N/A) |
|
Details | ||
| 11/11/2020 | ObsEva | OBSV | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2020 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2020 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2020 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2020 | Eiger BioPharma | EIGR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2020 | Sangamo BioSciences | SGMO | Maintain | Neutral (N/A) |
|
Details | ||
| 11/3/2020 | Lexicon Pharmaceuticals | LXRX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/2/2020 | Catabasis | CATB | Downgrade | Neutral (Outperform) |
1.34 (8.54) |
537.31% | Details | |
| 11/2/2020 | Pacira Pharmaceuticals | PCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2020 | United Therapeutics Corp. | UTHR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/28/2020 | Kala Pharmaceuticals | KALA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/6/2020 | miRagen Therapeutics | MGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/28/2020 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 9/14/2020 | Immunic Inc. | IMUX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/10/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/8/2020 | Albireo Pharma | ALBO | Maintain | Outperform (N/A) |
|
Details | ||
| 9/8/2020 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 9/1/2020 | Omeros Corp. | OMER | Maintain | Neutral (N/A) |
|
Details | ||
| 9/1/2020 | Aimmune Therapeutics | AIMT | Downgrade | Neutral (Outperform) |
12.60 (34.49) |
173.73% | Details | |
| 8/20/2020 | United Therapeutics Corp. | UTHR | Maintain | Outperform (N/A) |
|
Details | ||
| 8/19/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/19/2020 | Clearside Biomedical | CLSD | Maintain | Outperform (N/A) |
|
Details | ||
| 8/19/2020 | Clearside Biomedical | CLSD | Maintain | Outperform (N/A) |
|
Details | ||
| 8/14/2020 | Axcella Health Inc. | AXLA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2020 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2020 | Immunic Inc. | IMUX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/3/2020 | Lexicon Pharmaceuticals | LXRX | Maintain | Neutral (N/A) |
|
Details | ||
| 7/30/2020 | United Therapeutics Corp. | UTHR | Maintain | Outperform (N/A) |
|
Details | ||
| 7/14/2020 | Albireo Pharma | ALBO | Maintain | Outperform (N/A) |
|
Details | ||
| 7/8/2020 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 6/17/2020 | Immunic Inc. | IMUX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/5/2020 | Immunic Inc. | IMUX | New Coverage | Outperform (N/A) |
12.19 (15.16) |
24.36% | Details | |
| 6/4/2020 | Eiger BioPharma | EIGR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/28/2020 | Axcella Health Inc. | AXLA | New Coverage | Outperform (N/A) |
5.45 (4.58) |
-15.96% | Details | |
| 5/13/2020 | miRagen Therapeutics | MGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/27/2020 | Omeros Corp. | OMER | Maintain | Neutral (N/A) |
|
Details | ||
| 4/20/2020 | Verona Pharma | VRNA | Maintain | Outperform (N/A) |
|
Details | ||
| 4/8/2020 | Liquidia Technologies | LQDA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/24/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/24/2020 | ObsEva | OBSV | Maintain | Outperform (N/A) |
|
Details | ||
| 3/23/2020 | XOMA, Ltd. | XOMA | Maintain | Neutral (N/A) |
|
Details | ||
| 3/17/2020 | Kala Pharmaceuticals | KALA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/12/2020 | Clearside Biomedical | CLSD | Maintain | Outperform (N/A) |
|
Details | ||
| 3/10/2020 | Catabasis | CATB | Maintain | Outperform (N/A) |
|
Details | ||
| 3/10/2020 | Kala Pharmaceuticals | KALA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/5/2020 | ObsEva | OBSV | Maintain | Outperform (N/A) |
|
Details | ||
| 3/3/2020 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/21/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/10/2020 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 2/5/2020 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/3/2020 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 1/13/2020 | Verona Pharma | VRNA | Maintain | Outperform (N/A) |
|
Details | ||
| 12/26/2019 | Liquidia Technologies | LQDA | Maintain | Outperform (N/A) |
|
Details | ||
| 12/26/2019 | Liquidia Technologies | LQDA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/26/2019 | Global Blood Therapeutics | GBT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/26/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/25/2019 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 11/22/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/20/2019 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/24/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/22/2019 | United Therapeutics Corp. | UTHR | Maintain | Outperform (N/A) |
|
Details | ||
| 9/6/2019 | Zafgen | ZFGN | Downgrade | Neutral (Outperform) |
0.70 (0.99) |
41.43% | Details | |
| 9/5/2019 | Global Blood Therapeutics | GBT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/29/2019 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 8/22/2019 | Clearside Biomedical | CLSD | Maintain | Outperform (N/A) |
|
Details | ||
| 7/2/2019 | Allena Pharmaceuticals | ALNA | Maintain | Outperform (Outperform) |
|
Details | ||
| 6/24/2019 | Sangamo BioSciences | SGMO | Maintain | Neutral (N/A) |
|
Details | ||
| 6/10/2019 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/2/2019 | United Therapeutics Corp. | UTHR | Maintain | Outperform (N/A) |
|
Details | ||
| 4/26/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/23/2019 | Eiger BioPharma | EIGR | Maintain | Outperform (N/A) |
|
Details | ||
| 4/8/2019 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 3/25/2019 | Lexicon Pharmaceuticals | LXRX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/19/2019 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/18/2019 | miRagen Therapeutics | MGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/12/2019 | Liquidia Technologies | LQDA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/12/2019 | Omeros Corp. | OMER | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2019 | Lexicon Pharmaceuticals | LXRX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/22/2019 | Catabasis | CATB | Maintain | Outperform (N/A) |
|
Details | ||
| 2/19/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 1/29/2019 | Catabasis | CATB | Maintain | Outperform (N/A) |
|
Details | ||
| 1/22/2019 | Lexicon Pharmaceuticals | LXRX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/27/2018 | Liquidia Technologies | LQDA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/12/2018 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/13/2018 | Aquestive Therapeutics | AQST | New Coverage | Outperform (N/A) |
18.28 (4.12) |
-77.46% | Details | |
| 9/5/2018 | Liquidia Technologies | LQDA | New Coverage | Outperform (N/A) |
15.34 (79.94) |
421.12% | Details |
